Medical Journals

Altered Hiv-1 Gag Protein Interactions with Cyclophilin A (Cypa) on the Acquisition of H219q and H219p Substitutions in the Cypa Binding Loop.

Authors:
  • Gatanaga Hiroyuki
  • Das Debananda
  • Suzuki Yasuhiro
  • Yeh Damaris D
  • Hussain Khaja A
  • Ghosh Arun K
  • Mitsuya Hiroaki

From: Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, NCI, National Institutes of Health, Bethesda, MD 20892, USA.

The Journal of biological chemistry

  • Publish Date: Jan 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 2
  • Pages: 1241-50
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gatanaga Hiroyuki, Das Debananda, Suzuki Yasuhiro, et al. Altered Hiv-1 Gag Protein Interactions with Cyclophilin A (Cypa) on the Acquisition of H219q and H219p Substitutions in the Cypa Binding Loop.. J. Biol. Chem. Jan 2006;281:1241-50

Abstract

HIV-1 Gag protein interaction with cyclophilin A (CypA) is critical for viral fitness. Among the amino acid substitutions identified in Gag noncleavage sites in HIV-1 variants resistant to protease inhibitors, H219Q (Gatanaga, H., Suzuki, Y., Tsang, H., Yoshimura, K., Kavlick, M. F., Nagashima, K., Gorelick, R. J., Mardy, S., Tang, C., Summers, M. F., and Mitsuya, H. (2002) J. Biol. Chem. 277, 5952-5961) and H219P substitutions in the viral CypA binding loop confer the greatest replication advantage to HIV-1. These substitutions represent polymorphic amino acid residues. We found that the replication advantage conferred by these substitutions was far greater in CypA-rich MT-2 and H9 cells than in Jurkat cells and peripheral blood mononuclear cells (PBM), both of which contained less CypA. High intracellular CypA content in H9 and MT-2 cells, resulting in excessive CypA levels in virions, limited wild-type HIV-1 (HIV-1(WT)) replication and H219Q introduction into HIV-1 (HIV-1(H219Q)), reduced CypA incorporation of HIV-1, and potentiated viral replication. H219Q introduction also restored the otherwise compromised replication of HIV-1(P222A) in PBM, although the CypA content in HIV-1(H219Q/P222A) was comparable with that in HIV-1(P222A), suggesting that H219Q affected the conformation of the CypA-binding motif, rendering HIV-1 replicative in a low CypA environment. Structural modeling analyses revealed that although hydrogen bonds are lost with H219Q and H219P substitutions, no significant distortion of the CypA binding loop of Gag occurred. The loop conformation of HIV-1(P222A) was found highly distorted, although H219Q introduction to HIV-1 restored the conformation of the loop close to that of HIV-1 (P222A). The present data suggested that the effect of CypA on HIV-1 replicative (WT) ability is bimodal (both high and low CypA content limits HIV-1 replication), that the conformation of the CypA binding region of Gag is important for viral fitness, and that the function of CypA is to maintain the conformation.

Mesh Headings (Keywords): Amino Acid Motifs, Animals, Blotting, Western, CD4-Positive T-Lymphocytes, COS Cells, Cell Line, Cercopithecus aethiops, Cyclophilin A, Enzyme Inhibitors, HIV Core Protein p24, HIV-1, Humans, Hydrogen Bonding, Jurkat Cells, Kinetics, Leukocytes, Mononuclear, Models, Chemical, Models, Molecular, Molecular Conformation, Mutation, Peptide Hydrolases, Protein Binding, Protein Conformation, Protein Structure, Tertiary, Recombinant Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 16275650


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.